Report of Foreign Issuer (6-k)
March 21 2018 - 7:27AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
March 2018
Commission file number: 001-36288
Akari
Therapeutics, Plc
(Translation of registrant's name into English)
75/76 Wimpole Street
London W1G 9RT
United Kingdom
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will
file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F
x
Form
40-F
¨
Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulations S-T Rule 101(b)(1):_____
Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulations S-T Rule 101(b)(7):_____
CONTENTS
On March 21, 2018,
Akari Therapeutics, Plc, (the “Company”) issued a press release announcing fourth quarter and full year 2017 financial
results and highlights on its clinical development programs. A copy of the press release is attached hereto as Exhibit 99.1 and
incorporated herein by reference.
The statements under “Fourth Quarter
and Full Year 2017 Financial Results”, the accompanying financial statements and “Forward Looking Statements”
of Exhibit 99.1 are hereby incorporated by reference into all effective registration statements filed by the Company under the
Securities Act of 1933.
Exhibit No.
99.1
|
Press Release dated March 21, 2018.
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
Akari Therapeutics, Plc
|
|
|
(Registrant)
|
|
|
|
|
|
|
By:
|
/s/ David Horn Solomon
|
|
|
Name:
|
David Horn Solomon
|
|
|
Chief Executive Officer
|
|
Date: March 21, 2018
Akari Therapeutics (NASDAQ:AKTX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Akari Therapeutics (NASDAQ:AKTX)
Historical Stock Chart
From Apr 2023 to Apr 2024